With Lilly’s recent launch of additional doses of Zepbound vials and reduced pricing of existing vial doses, the integration will provide LifeMD’s eligible on-label patients with streamlined ...

Telehealth firms Teladoc and LifeMD said on Thursday they had signed an agreement to offer Eli Lilly's weight-loss drug Zepbound to self-paying patients, ahead of restrictions on selling copies known ...

Earlier this week, Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial Zepbound (tirzepatide) to patients in the virtual care companies ...

LifeMD on Thursday said it will integrate with Eli Lilly's online pharmacy and healthcare platform to offer access to Lilly's prescription obesity treatment Zepbound in single-dose vials.

Integration with the LillyDirect ® self-pay pharmacy channel will provide a seamless solution to a patient's Zepbound fulfillment journey while continuing to offer more accessible pricing and direct ...